Hong Jae Chon
Hong Jae Chon publishes mostly in Oncology, Hepatology and Pulmonary and Respiratory Medicine, on topics such as Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies and Cancer Immunotherapy and Biomarkers.
- World rank
- #108,375 of 7,710,434 ranked researchers
- Rank in South Korea
- #521 of 162,609
- Works
- 282
- Citations
- 7.9k
- Citations per work
- 28.1
What does Hong Jae Chon research?
Hong Jae Chon's work is mostly in Medicine (75%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences21174.7%
- Medicine21174.7%
- Everything else5519.5%
- Life Sciences165.8%
- 1Oncology24% of their works
- 2Hepatology18% of their works
- 3Pulmonary and Respiratory Medicine14% of their works
- 4Surgery14% of their works
- 5Immunology6% of their works
- 6Epidemiology4% of their works
Research topics
- Hepatocellular Carcinoma Treatment and Prognosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Gallbladder and Bile Duct Disorders
- Pancreatic and Hepatic Oncology Research
- Gastric Cancer Management and Outcomes
- Ferroptosis and cancer prognosis
Which keywords describe Hong Jae Chon's research?
The keywords of their largest research topics: Clinical Practice Guidelines, Tumor Microenvironment, Cholangiocarcinoma, Hepatocellular Carcinoma, Liver Cancer, Chemotherapy, Biliary Tract Cancer and Intrahepatic Cholangiocarcinoma.
- Ferroptosis
- Gastric Cancer
- Surgical Complications
- ERCP
- KRAS Mutations
- PD-1 and PD-L1
- Intrahepatic Cholangiocarcinoma
- Chemotherapy
- Hepatocellular Carcinoma
- Tumor Microenvironment
- Clinical Practice Guidelines
- Cholangiocarcinoma
- Liver Cancer
- Biliary Tract Cancer
- Immune Checkpoint Blockade
- Cetuximab
- Cholecystitis
- Pancreatic Cancer
- Endoscopic Resection
- Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Clinical Practice Guidelines1402 topics
- Tumor Microenvironment1273 topics
- Cholangiocarcinoma1252 topics
- Hepatocellular Carcinoma1151 topic
- Liver Cancer1151 topic
- Chemotherapy913 topics
- Biliary Tract Cancer901 topic
- Intrahepatic Cholangiocarcinoma901 topic
- Immune Checkpoint Blockade821 topic
- PD-1 and PD-L1821 topic
- Cetuximab391 topic
- KRAS Mutations391 topic
- Cholecystitis351 topic
- ERCP351 topic
- Pancreatic Cancer271 topic
- Surgical Complications271 topic
- Endoscopic Resection251 topic
- Gastric Cancer251 topic
- Cancer181 topic
- Ferroptosis181 topic
Where does Hong Jae Chon work?
Hong Jae Chon's main affiliation in the publication record is CHA University Bundang Medical Center, South Korea.
How many publications and citations does Hong Jae Chon have?
OpenAlex counts 282 works and 7,926 citations for Hong Jae Chon, an h-index of 44, ranking #108,375 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Hong Jae Chon
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hong Jae Chon. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.